Published:
Key Takeaways
- Blue Goat Cyber launched a new service securing legacy medical devices with advanced monitoring and testing.
- The service starts with SAST, SBOM generation, and penetration testing for thorough vulnerability assessment.
- Post-assessment, Blue Goat Cyber offers ongoing SBOM monitoring, routine pentesting, and a CVD portal.
- This offering helps manufacturers meet regulatory compliance and protect patient safety from aging tech risks.
- Static Application Security Testing (SAST) scans the device’s source code, identifying hidden vulnerabilities that attackers could exploit. SAST is particularly crucial for legacy devices, where code structures may lack modern security features.
- Software Bill of Materials (SBOM) creation offers a comprehensive inventory of all software components within the device, including third-party and open-source libraries. By identifying components with outdated or unsupported software, the SBOM provides a foundation for ongoing vulnerability management, addressing hidden risks often found in legacy systems.
- Penetration Testing simulates real-world cyberattacks, exposing the device’s vulnerabilities in its current state and testing its resilience against potential threats. This phase offers manufacturers a clear picture of their device’s security posture and serves as a foundation for building a targeted and effective security strategy.
- SBOM Monitoring ensures ongoing visibility of all software components in the device, alerting manufacturers to potential vulnerabilities as they arise. This proactive approach is essential for legacy devices that rely on components from multiple vendors, some of which may introduce new vulnerabilities over time.
- Routine Penetration Testing is conducted regularly, simulating new and evolving cyber threats to ensure that devices remain resilient against the latest attack methods. This routine testing allows Blue Goat Cyber to continually refine the device’s security posture, helping manufacturers stay one step ahead of cyber threats.
- The Coordinated Vulnerability Disclosure (CVD) Portal provides a secure, structured way for healthcare providers, researchers, and manufacturers to report and track vulnerabilities in legacy devices. This centralized system supports transparent communication among stakeholders, ensuring vulnerabilities are addressed quickly and thoroughly while maintaining regulatory compliance.
SCOTTSDALE, AZ, UNITED STATES, October 30, 2024
Blue Goat Cyber, a medical device cybersecurity solutions leader, has announced a new service dedicated to securing legacy medical devices. Aimed at addressing the unique vulnerabilities of aging healthcare technology, this service begins with a thorough cybersecurity assessment, including Static Application Security Testing (SAST), Software Bill of Materials (SBOM) generation, and penetration testing. Following the initial assessment, Blue Goat Cyber offers a postmarket management contract featuring SBOM monitoring, routine penetration testing, and a Coordinated Vulnerability Disclosure (CVD) portal, supporting long-term device protection and regulatory compliance.
Legacy medical devices, often operating on outdated software and hardware, pose heightened cybersecurity risks that can affect patient safety and regulatory compliance. Blue Goat Cyber’s new service delivers a tailored approach to securing these devices, providing a clear roadmap for addressing vulnerabilities and enabling manufacturers to maintain security standards over time.